TY - JOUR
T1 - Benefit‐cost analysis of addiction treatment in Arkansas
T2 - Specialty and standard residential programs for pregnant and parenting women
AU - McCollister, Kathryn E.
AU - French, Michael T.
AU - Cacciola, John
AU - Durell, Jack
AU - Stephens, Raymond L.
AU - French, Michael T.
N1 - Funding Information:
Financial assistance for this study was provided by the Center for Substance Abuse Treatment (Grant No. 270-97-7020) and the National Institute on Drug Abuse (Grant Nos. 1R01 DA11506 and 2P50 DA07705). We are grateful to Kathy Geary, Jarrod Cecere, and Walter Hathaway for project management and data collection; Quansheng Shen for his data management support; Silvana Zavala for her research assistance; Tom McLellan and Helena Salomé for helpful suggestion on previous versions of the paper; and Carmen Martinez for her administrative and editorial assistance. The authors are entirely responsible for the research and results reported in this paper, and their position or opinions do not necessarily represent those of the University of Miami, DeltaMetrics, or the State of Arkansas.
PY - 2002/3/1
Y1 - 2002/3/1
N2 - A benefit-cost analysis of specialty residential treatment (Specialty) and standard residential treatment (Standard) was conducted on a sample of pregnant and parenting substance abusers from Arkansas. Economic benefits were derived from client self-reported information at treatment entry and at 6-month postdischarge with the use of an augmented version of the Addiction Severity Index (ASI). The average cost of treatment in Specialty programs was $8,035 versus $1,467 for Standard residential treatment. Average net benefits (benefit-cost ratios) were estimated to be $17,144 (3.1) for Specialty and $8,090 (6.5) for Standard. The main policy implication of this research is that investment in Specialty residential treatment for pregnant and parenting substance-abusing women appears to be economically justified, but future evaluations should analyze larger and more comparable samples to improve power and precision in the benefit-cost statistics.
AB - A benefit-cost analysis of specialty residential treatment (Specialty) and standard residential treatment (Standard) was conducted on a sample of pregnant and parenting substance abusers from Arkansas. Economic benefits were derived from client self-reported information at treatment entry and at 6-month postdischarge with the use of an augmented version of the Addiction Severity Index (ASI). The average cost of treatment in Specialty programs was $8,035 versus $1,467 for Standard residential treatment. Average net benefits (benefit-cost ratios) were estimated to be $17,144 (3.1) for Specialty and $8,090 (6.5) for Standard. The main policy implication of this research is that investment in Specialty residential treatment for pregnant and parenting substance-abusing women appears to be economically justified, but future evaluations should analyze larger and more comparable samples to improve power and precision in the benefit-cost statistics.
KW - Addiction treatment
KW - Benefit-cost analysis
KW - Pregnant and parenting women
UR - http://www.scopus.com/inward/record.url?scp=0036490405&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036490405&partnerID=8YFLogxK
U2 - 10.1080/08897070209511473
DO - 10.1080/08897070209511473
M3 - Article
C2 - 12444359
AN - SCOPUS:0036490405
VL - 23
SP - 31
EP - 51
JO - Substance Abuse
JF - Substance Abuse
SN - 0889-7077
IS - 1
ER -